Author
Listed:
- Daniela K Schlüter
- Martial L Ndeffo-Mbah
- Innocent Takougang
- Tony Ukety
- Samuel Wanji
- Alison P Galvani
- Peter J Diggle
Abstract
Lymphatic Filariasis and Onchocerciasis (river blindness) constitute pressing public health issues in tropical regions. Global elimination programs, involving mass drug administration (MDA), have been launched by the World Health Organisation. Although the drugs used are generally well tolerated, individuals who are highly co-infected with Loa loa are at risk of experiencing serious adverse events. Highly infected individuals are more likely to be found in communities with high prevalence. An understanding of the relationship between individual infection and population-level prevalence can therefore inform decisions on whether MDA can be safely administered in an endemic community. Based on Loa loa infection intensity data from individuals in Cameroon, the Republic of the Congo and the Democratic Republic of the Congo we develop a statistical model for the distribution of infection levels in communities. We then use this model to make predictive inferences regarding the proportion of individuals whose parasite count exceeds policy-relevant levels. In particular we show how to exploit the positive correlation between community-level prevalence and intensity of infection in order to predict the proportion of highly infected individuals in a community given only prevalence data from the community in question. The resulting prediction intervals are not substantially wider, and in some cases narrower, than the corresponding binomial confidence intervals obtained from data that include measurements of individual infection levels. Therefore the model developed here facilitates the estimation of the proportion of individuals highly infected with Loa loa using only estimated community level prevalence. It can be used to assess the risk of rolling out MDA in a specific community, or to guide policy decisions.Author Summary: Lymphatic Filariasis (LF) is caused by parasitic worms which live in the lymphatic system. Though several body parts may be affected, LF characteristically leads to the enlargement of limbs, causing pain, physical disability and social stigma. Onchocerciasis (river blindness) is caused by similar worms which inhabit the subcutaneous tissue and lead to disturbing skin lesions, visual impairment and blindness. Onchocerciasis and LF affect over 146 million people, and have been targeted for elimination as public health problems by the World Health Organisation, using mass drug administration (MDA). Although the drugs used in MDA are generally well tolerated, individuals who are highly co-infected with Loa loa are at risk of experiencing serious adverse events. In order to inform decisions on whether MDA can be safely administered in a community, we investigate the relationship between community level prevalence of Loa loa and individual infection levels through the development of a statistical model. We find a strong positive correlation and show how this can be exploited to estimate the proportion of individuals highly infected with Loa loa without the need for data on individual infection levels. The model therefore provides a method to assess the risk of rolling out MDA in a specific community, or to guide policy decisions.
Suggested Citation
Daniela K Schlüter & Martial L Ndeffo-Mbah & Innocent Takougang & Tony Ukety & Samuel Wanji & Alison P Galvani & Peter J Diggle, 2016.
"Using Community-Level Prevalence of Loa loa Infection to Predict the Proportion of Highly-Infected Individuals: Statistical Modelling to Support Lymphatic Filariasis and Onchocerciasis Elimination Pro,"
PLOS Neglected Tropical Diseases, Public Library of Science, vol. 10(12), pages 1-15, December.
Handle:
RePEc:plo:pntd00:0005157
DOI: 10.1371/journal.pntd.0005157
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pntd00:0005157. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosntds (email available below). General contact details of provider: https://journals.plos.org/plosntds/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.